MGI Tech Co., Ltd. engages in the research and development, production, and sale of DNA sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. It produces clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation. Its products and services cover the following sectors: Gene Sequencer Business, Laboratory Automation Business, and New Business. The Gene Sequencer Business includes gene sequencer and supporting equipment, and sequencing kit reagents. The Laboratory Automation Business is comprised of the automated sample processing system, laboratory automation assembly line, and sample processing reagent consumables. The New Business focuses on cytomics solutions, remote ultrasonic robot, and BIT products. The company was founded on April 13, 2016 and is headquartered in Shenzhen, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company